Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs ADVANCED ENZYME TECHNOLOGIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA ADVANCED ENZYME TECHNOLOGIES NATCO PHARMA/
ADVANCED ENZYME TECHNOLOGIES
 
P/E (TTM) x 12.6 29.6 42.6% View Chart
P/BV x 4.2 3.2 132.9% View Chart
Dividend Yield % 0.7 1.4 50.6%  

Financials

 NATCO PHARMA   ADVANCED ENZYME TECHNOLOGIES
EQUITY SHARE DATA
    NATCO PHARMA
Mar-24
ADVANCED ENZYME TECHNOLOGIES
Mar-24
NATCO PHARMA/
ADVANCED ENZYME TECHNOLOGIES
5-Yr Chart
Click to enlarge
High Rs1,108425 260.6%   
Low Rs550233 236.3%   
Sales per share (Unadj.) Rs223.355.8 400.2%  
Earnings per share (Unadj.) Rs77.512.2 632.9%  
Cash flow per share (Unadj.) Rs87.915.4 571.1%  
Dividends per share (Unadj.) Rs9.505.10 186.3%  
Avg Dividend yield %1.11.6 73.9%  
Book value per share (Unadj.) Rs326.8118.1 276.6%  
Shares outstanding (eoy) m179.11111.82 160.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.75.9 63.0%   
Avg P/E ratio x10.726.9 39.8%  
P/CF ratio (eoy) x9.421.4 44.1%  
Price / Book Value ratio x2.52.8 91.1%  
Dividend payout %12.341.6 29.4%   
Avg Mkt Cap Rs m148,50936,793 403.6%   
No. of employees `000NANA-   
Total wages/salary Rs m5,2501,284 409.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m39,9886,239 641.0%  
Other income Rs m1,281370 346.5%   
Total revenues Rs m41,2696,608 624.5%   
Gross profit Rs m17,5141,902 920.8%  
Depreciation Rs m1,868352 530.0%   
Interest Rs m19241 465.9%   
Profit before tax Rs m16,7351,878 891.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,852509 560.6%   
Profit after tax Rs m13,8831,370 1,013.7%  
Gross profit margin %43.830.5 143.7%  
Effective tax rate %17.027.1 62.9%   
Net profit margin %34.722.0 158.2%  
BALANCE SHEET DATA
Current assets Rs m40,2358,097 496.9%   
Current liabilities Rs m9,7281,064 914.7%   
Net working cap to sales %76.3112.7 67.7%  
Current ratio x4.17.6 54.3%  
Inventory Days Days62248 25.0%  
Debtors Days Days10958 188.2%  
Net fixed assets Rs m28,6347,114 402.5%   
Share capital Rs m358224 160.1%   
"Free" reserves Rs m58,17312,987 447.9%   
Net worth Rs m58,53113,211 443.0%   
Long term debt Rs m070 0.0%   
Total assets Rs m68,86915,212 452.7%  
Interest coverage x88.246.6 189.3%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.60.4 141.6%   
Return on assets %20.49.3 220.4%  
Return on equity %23.710.4 228.8%  
Return on capital %28.914.5 200.1%  
Exports to sales %017.6 0.0%   
Imports to sales %9.59.5 99.7%   
Exports (fob) Rs mNA1,097 0.0%   
Imports (cif) Rs m3,798594 639.0%   
Fx inflow Rs m27,3471,097 2,493.8%   
Fx outflow Rs m3,798594 639.0%   
Net fx Rs m23,549502 4,688.6%   
CASH FLOW
From Operations Rs m12,1161,414 857.0%  
From Investments Rs m-10,327-646 1,597.4%  
From Financial Activity Rs m-2,469-592 416.8%  
Net Cashflow Rs m-615173 -354.9%  

Share Holding

Indian Promoters % 49.6 2.0 2,506.1%  
Foreign collaborators % 0.0 41.0 -  
Indian inst/Mut Fund % 24.3 20.7 117.5%  
FIIs % 17.5 12.6 138.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 50.4 57.1 88.3%  
Shareholders   302,944 66,758 453.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Natco Pharma vs ADVANCED ENZYME TECHNOLOGIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Natco Pharma vs ADVANCED ENZYME TECHNOLOGIES Share Price Performance

Period Natco Pharma ADVANCED ENZYME TECHNOLOGIES S&P BSE HEALTHCARE
1-Day -0.44% 0.26% 0.78%
1-Month 3.04% -15.50% -0.69%
1-Year 71.17% 12.81% 42.97%
3-Year CAGR 19.28% 4.55% 20.17%
5-Year CAGR 19.75% 17.23% 26.13%

* Compound Annual Growth Rate

Here are more details on the Natco Pharma share price and the ADVANCED ENZYME TECHNOLOGIES share price.

Moving on to shareholding structures...

The promoters of Natco Pharma hold a 49.6% stake in the company. In case of ADVANCED ENZYME TECHNOLOGIES the stake stands at 43.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Natco Pharma and the shareholding pattern of ADVANCED ENZYME TECHNOLOGIES.

Finally, a word on dividends...

In the most recent financial year, Natco Pharma paid a dividend of Rs 9.5 per share. This amounted to a Dividend Payout ratio of 12.3%.

ADVANCED ENZYME TECHNOLOGIES paid Rs 5.1, and its dividend payout ratio stood at 41.6%.

You may visit here to review the dividend history of Natco Pharma, and the dividend history of ADVANCED ENZYME TECHNOLOGIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5% Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5%(10:30 am)

Asian markets traded higher on Friday, following the overnight rally on Wall Street, and the release of economic data in the region.